期刊文献+

循证医学与循值医学 被引量:4

From evidence-based medicine to value-based medicine
原文传递
导出
摘要 循证医学以客观证据为基础,使临床治疗决策科学化,是临床医疗模式的一次重大转变。其目的是遵循证据寻求最佳、最可靠的诊疗方案,以提高治疗效果,从而延长患者寿命。但寿命的延长并不意味着生活质量的提高,临床实践必须要兼顾患者的感受和意愿。循值医学则是建立在循证医学最佳证据的基础上,将其与患者生活质量及治疗的经济费用最大限度地结合起来,运用效用分析的方法对生活质量的“质”进行具体量化。这一新型医疗模式将为整个社会提供一种更好的用于评价治疗方案的工具,可为患者提供更高质量的医疗服务,同时最大限度地减轻社会的经济负担。(中华眼科杂志,2006,421042-1046) Evidence-based medicine (EBM) is based on objective evidence, which provides best available knowledge for physicians to scientifically make medical and therapeutic decisions for the care of all individual patients in order to improve the effectiveness of treatment and to prolong the life of patients. EBM has made a significant progress in clinical practice. But medical therapies cannot always bring a better life quality and clinically, patients' preference should be always taken into account. Value-based medicine (VBM) is the practice of medicine that emphasizes the value received from an intervention. It takes evidence-based data to a higher level by combining the parameters of patient-perceived value with the cost of an intervention. The fundamental instrument of VBM is cost-utility analysis. VBM will provide a better practice model to evaluate the therapeutic package and cost effectiveness for individual and general health care.
出处 《中华眼科杂志》 CAS CSCD 北大核心 2006年第11期1042-1046,共5页 Chinese Journal of Ophthalmology
关键词 证据医学 生活质量 费用效益分析 Evidencebased medicine Quality of life Cost-benefit analysis
  • 相关文献

参考文献26

  • 1Evidence-based medicine working group.Evidence-based medicine:a new approach to teaching the practice of medicine.J Am Med Assoc,1992,268:2420-2425.
  • 2Sackett DL,Rosenberg WMC,Gray JAM,et al.Evidence based medicine:what it is and what it isn′t.Br Med J,1996,312:71-72.
  • 3Brown GC.Value-based medicine:the new paradigm.Curr Opin Ophthalmol,2005,16:139-140.
  • 4Brown MM,Brown GC.Value-based medicine.Br J Ophthalmol,2004,88:979.
  • 5Jampel HD.Glaucoma patients′ assessment of their visual function and quality of life.Trans Am Ophthalmol Soc,2001,99:301-317.
  • 6Brown M.Utility analysis tells all.Br J Ophthalmol,2005,89:1233.
  • 7Gupta V,Srinivasan G,Mei SS,et al.Utility values among glaucoma patients:an impact on the quality of life.Br J Ophthalmol,2005,89:1241-1244.
  • 8Froberg DG,Kane RL.Methodology for measuring health-state preferences:Ⅳ.progress and a research agenda.J Clin Epidemiol,1989,42:675-685.
  • 9Froberg DG,Kane RL.Methodology for measuring health-state preferences-Ⅱ:scaling methods.J Clin Epidemiol,1989,42:459-471.
  • 10Stein JD,Brown MM,Brown GC,et al.Quality of life with macular degeneration:perceptions of patients,clinicians,and community members.Br J Ophthalmol,2003,87:8-12.

同被引文献33

引证文献4

二级引证文献10

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部